Advertisement
HomeCollectionsPiper Jaffray
IN THE NEWS

Piper Jaffray

FEATURED ARTICLES
BUSINESS
By BLOOMBERG NEWS | July 13, 2004
NEW YORK - Piper Jaffray Cos. was fined $2.4 million yesterday by the NASD for improper sales of initial public offerings to executives from companies including Liquid Audio Inc. and GoAmerica Inc. The agency accused the securities firm of "spinning" hot IPOs between 1999 and 2002, offering shares to 22 executives to try to win investment-banking business. The executives, mostly chief executives and chief financial officers in publicly traded companies, made a total of $2.4 million in profits, NASD said in a statement.
ARTICLES BY DATE
BUSINESS
By Eileen Ambrose, The Baltimore Sun | February 17, 2013
Raymond "Chip" Mason first met Joseph A. Sullivan over dinner at a Chicago restaurant, where the founder of Legg Mason Inc. interviewed the young bond trading manager for a job with the Baltimore company. A lot of the conversation, Mason recalled, was about whether Sullivan and his family were prepared to uproot themselves and move to the Charm City. Mason had seen such moves not work out before. "He admitted it would not be simple," said Mason, who retired after nearly 40 years at Legg's helm and now spends much of his time in Naples, Fla. But "he thought he could do more with us than anyone else.
Advertisement
BUSINESS
February 16, 1995
Piper Jaffray settles lawsuitPiper Jaffray Cos., a major mutual fund and brokerage firm, agreed yesterday to pay $70 million to settle a large lawsuit resulting from a bond fund's failed investment in exotic securities called mortgage derivatives.The settlement is one of the largest to result from huge losses several mutual funds suffered last year from investments in derivatives.
BUSINESS
By Hanah Cho ha and Hanah Cho ha,nah.cho@baltsun.com | November 5, 2008
Osiris Therapeutics announced yesterday that it has struck a marketing deal with a large biotechnology firm for two adult stem cell treatments worth up to $1.38 billion. The Columbia company and Massachusetts-based Genzyme Corp. have paired up to develop and sell Prochymal and Chondrogen, two late-stage adult stem cell treatments for several disorders. Osiris developed the treatments but will get financial support from Genzyme for further advancement and commercialization of the products.
BUSINESS
July 21, 2004
LOCALLY Laureate Education Inc.Shares of the Baltimore-based purveyor of undergraduate and graduate education programs in Europe and Latin America surged 4.6 percent yesterday to $38.94, their high this year, after Piper Jaffray & Co. raised its target price from $42 to $45. NATIONALLY AMC Entertainment Shares surged more than 23 percent yesterday, rising $3.19 to $17.41, on reports that private equity firm J.P. Morgan Partners was negotiating to...
BUSINESS
By BLOOMBERG NEWS | December 16, 1997
MINNEAPOLIS -- U.S. Bancorp, one of the nation's biggest banks, yesterday agreed to buy the century-old investment banking and brokerage concern Piper Jaffray Cos. Inc. for $730 million in cash.The transaction values Piper, a brokerage firm, at $37.25 a share. That is about four times book value -- assets minus liabilities -- a bigger premium than other banks paid this year to buy securities firms. Piper shares rose $6.625, or 22 percent, to $36.375 yesterday while U.S. Bancorp's stock rose $1.75 to to $115.
BUSINESS
By NEW YORK TIMES NEWS SERVICE | April 21, 2005
Pernod Ricard, a French spirits maker, and Fortune Brands, the consumer products conglomerate whose brands include Moen faucets and Jim Beam bourbon, will announce today that they are proceeding with plans to jointly acquire Allied Domecq, the British maker of brands such as Beefeater gin, Kahlua liqueur and Perrier Jouet and Mumm champagnes. "We are definitely going to make an offer," said Florence Taron, a spokeswoman for Pernod, adding that an announcement will be made today. The three companies confirmed more than two weeks ago that they were in talks, and Philip Bowman, Allied's chief executive, said at the time that he would consider the acquisition if the price was right.
BUSINESS
By BLOOMBERG NEWS | May 3, 2003
NEW YORK - New York State Attorney General Eliot Spitzer said yesterday that he expects criminal charges against some stock analysts stemming from this week's $1.4 billion settlement between Wall Street and regulators. The settlement, the biggest ever for violating securities laws, alleges that 10 firms published misleading stock research to win investment-banking business. Citigroup Inc., Credit Suisse First Boston and Merrill Lynch & Co. Inc. committed fraud, the authorities said. Regulators also barred former analysts Jack B. Grubman and Henry M. Blodget from the industry.
BUSINESS
By O. Casey Corr and O. Casey Corr,Seattle Times | April 13, 1991
SEATTLE -- The Federal Trade Commission's investigation of Microsoft Corp. has moved into far-reaching allegations that the company has monopolized operating systems for the nation's personal computers.Microsoft, which earlier characterized the investigation as the FTC pursuing a curiosity, said yesterday that it now faces a broader investigation."Microsoft is surprised and disappointed that the inquiry has been broadened," said William Neukom, Microsoft vice president for law and corporate affairs.
BUSINESS
By BLOOMBERG NEWS | December 16, 1997
NEW YORK -- U.S. stocks rose yesterday for the first time in six sessions, led by airlines such as UAL Corp. and beaten-up bank shares, including J. P. Morgan & Co., as investors called previous estimates of Asia's damage to U.S. profits too pessimistic."
BUSINESS
By TRICIA BISHOP and TRICIA BISHOP,SUN REPORTER | June 21, 2006
Human Genome Sciences announced yesterday its first major contract with the U.S. government for an experimental anthrax drug, more than four years after the bacterial infection terrorized the country. But Wall Street's initial reaction was tepid. The federal government plans to purchase 20,000 doses of the Rockville biotech's treatment for $165.2 million, with delivery and 90 percent of the payment expected in 2008. When complete, the deal will give the 14-year-old company its first-ever product sales revenue.
BUSINESS
By NEW YORK TIMES NEWS SERVICE | April 21, 2005
Pernod Ricard, a French spirits maker, and Fortune Brands, the consumer products conglomerate whose brands include Moen faucets and Jim Beam bourbon, will announce today that they are proceeding with plans to jointly acquire Allied Domecq, the British maker of brands such as Beefeater gin, Kahlua liqueur and Perrier Jouet and Mumm champagnes. "We are definitely going to make an offer," said Florence Taron, a spokeswoman for Pernod, adding that an announcement will be made today. The three companies confirmed more than two weeks ago that they were in talks, and Philip Bowman, Allied's chief executive, said at the time that he would consider the acquisition if the price was right.
BUSINESS
By Joseph Menn and Joseph Menn,LOS ANGELES TIMES | December 14, 2004
SAN FRANCISCO - The board of PeopleSoft Inc. bowed to its investors yesterday - and to one of the most aggressive executives in Silicon Valley - by agreeing to sell the company to Oracle Corp. for $10.3 billion. The deal caps a bitter, often personal 18-month fight that captivated Wall Street and Silicon Valley, even though few casual computer users know much about either company's products. Yesterday's agreement was reached over the weekend, during the first direct negotiations between Oracle and People- Soft.
BUSINESS
July 21, 2004
LOCALLY Laureate Education Inc.Shares of the Baltimore-based purveyor of undergraduate and graduate education programs in Europe and Latin America surged 4.6 percent yesterday to $38.94, their high this year, after Piper Jaffray & Co. raised its target price from $42 to $45. NATIONALLY AMC Entertainment Shares surged more than 23 percent yesterday, rising $3.19 to $17.41, on reports that private equity firm J.P. Morgan Partners was negotiating to...
BUSINESS
By BLOOMBERG NEWS | July 13, 2004
NEW YORK - Piper Jaffray Cos. was fined $2.4 million yesterday by the NASD for improper sales of initial public offerings to executives from companies including Liquid Audio Inc. and GoAmerica Inc. The agency accused the securities firm of "spinning" hot IPOs between 1999 and 2002, offering shares to 22 executives to try to win investment-banking business. The executives, mostly chief executives and chief financial officers in publicly traded companies, made a total of $2.4 million in profits, NASD said in a statement.
BUSINESS
September 14, 2003
NITA PERIMAN didn't pay much notice to the pile of letters from her broker when she returned home to Montana from a series of trips in 2000. But then, she said, her hair stylist told her that the broker was a day trader. She said she opened the letters and discovered confirmations for a blizzard of trades. Later, state regulators determined that about 150 of them were unauthorized. The broker sold her conservative mutual funds and bought high-tech stocks, she said, generating $50,000 in commissions in one two-month period.
BUSINESS
By Hanah Cho ha and Hanah Cho ha,nah.cho@baltsun.com | November 5, 2008
Osiris Therapeutics announced yesterday that it has struck a marketing deal with a large biotechnology firm for two adult stem cell treatments worth up to $1.38 billion. The Columbia company and Massachusetts-based Genzyme Corp. have paired up to develop and sell Prochymal and Chondrogen, two late-stage adult stem cell treatments for several disorders. Osiris developed the treatments but will get financial support from Genzyme for further advancement and commercialization of the products.
BUSINESS
September 14, 2003
NITA PERIMAN didn't pay much notice to the pile of letters from her broker when she returned home to Montana from a series of trips in 2000. But then, she said, her hair stylist told her that the broker was a day trader. She said she opened the letters and discovered confirmations for a blizzard of trades. Later, state regulators determined that about 150 of them were unauthorized. The broker sold her conservative mutual funds and bought high-tech stocks, she said, generating $50,000 in commissions in one two-month period.
BUSINESS
By BLOOMBERG NEWS | May 3, 2003
NEW YORK - New York State Attorney General Eliot Spitzer said yesterday that he expects criminal charges against some stock analysts stemming from this week's $1.4 billion settlement between Wall Street and regulators. The settlement, the biggest ever for violating securities laws, alleges that 10 firms published misleading stock research to win investment-banking business. Citigroup Inc., Credit Suisse First Boston and Merrill Lynch & Co. Inc. committed fraud, the authorities said. Regulators also barred former analysts Jack B. Grubman and Henry M. Blodget from the industry.
BUSINESS
By BLOOMBERG NEWS | December 16, 1997
MINNEAPOLIS -- U.S. Bancorp, one of the nation's biggest banks, yesterday agreed to buy the century-old investment banking and brokerage concern Piper Jaffray Cos. Inc. for $730 million in cash.The transaction values Piper, a brokerage firm, at $37.25 a share. That is about four times book value -- assets minus liabilities -- a bigger premium than other banks paid this year to buy securities firms. Piper shares rose $6.625, or 22 percent, to $36.375 yesterday while U.S. Bancorp's stock rose $1.75 to to $115.
Baltimore Sun Articles
|
|
|
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.